Bridgewater Advisors Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1600319 NEW YORK, NY

Position in VRTX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$547,893

+$52,681 QoQ

Shares Held

1,103

-0.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#1,039

of 1,735 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bridgewater Advisors Inc. holds $1,270,177 across 4 Biotechnology names. VRTX ranks #1 (43.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,103	$547,893
2	ARGX	Argenx SE	335	$310,802
3	REGN	Regeneron Pharmaceuticals, Inc.	340	$212,003
4	TTRX	Turn Therapeutics Inc.	27,326	$199,479

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$547,893	1,103	-0.5%	Shares	Sole	2026-08-05
2026-03-31	$495,212	1,109	+3.1%	Shares	Sole	2026-05-14
2025-12-31	$487,815	1,076	+0.7%	Shares	Sole	2026-01-23
2025-09-30	$418,663	1,069	-2.6%	Shares	Sole	2025-11-10
2025-06-30	$488,384	1,097	-1.4%	Shares	Sole	2025-08-05
2025-03-31	$539,604	1,113	—	Shares	Sole	2025-05-02
No filing history on record for this holder in this stock.